Financial Ratios

VELVETTE INTERNATIONAL PHARMA PRODUCTS LTD.

NSE : NABSE : 524528ISIN CODE : INE042F01013Industry : Household & Personal ProductsHouse : Private
BSE3.100 (0 %)
PREV CLOSE ( ) 3.10
OPEN PRICE ( ) 3.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )3.00 3.10
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2005Mar2004Mar2002Mar2001Mar2000
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.54-0.58-27.030.300.06
   CEPS(Rs)-1.31-0.32-26.690.670.47
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-10.94-10.29-15.4510.399.23
   Tax Rate(%)0.000.000.0017.200.00
Margin Ratios
   Core EBITDA Margin(%)-72.70-3.09-241.679.6820.80
   EBIT Margin(%)-77.75-4.90-243.1011.6018.93
   Pre Tax Margin(%)-82.30-5.62-253.922.600.36
   PAT Margin (%)-82.30-5.62-253.922.150.36
   Cash Profit Margin (%)-69.95-3.08-250.804.762.87
Performance Ratios
   ROA(%)-8.56-3.04-71.940.620.12
   ROE(%)0.000.000.003.100.66
   ROCE(%)-12.84-4.63-98.734.288.51
   Asset Turnover(x)0.100.540.280.290.34
   Sales/Fixed Asset(x)0.251.411.131.501.73
   Working Capital/Sales(x)0.241.221.200.410.50
Efficiency Ratios
   Fixed Capital/Sales(x)4.040.710.890.670.58
   Receivable days893.23177.31638.13775.91649.37
   Inventory Days60.4531.3644.069.563.01
   Payable days1373.11296.16280.37194.74234.74
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.00-5.070.000.000.00
   Price/Book(x)0.00-0.160.000.000.00
   Yield(%)0.00
   EV/Net Sales(x)16.902.263.622.672.33
   EV/Core EBITDA(x)-25.85-95.55-1.5118.8010.85
   EV/EBIT(x)-21.74-46.06-1.4923.0312.29
   EV/CE(x)1.861.241.500.760.78
   M Cap / Sales0.000.160.000.000.00
Growth Ratio
   Net Sales Growth(%)-82.0328.91-24.80-13.6822.23
   Core EBITDA Growth(%)-397.1198.73-1369.30-42.7543.19
   EBIT Growth(%)-184.9197.40-1675.22-47.0756.71
   PAT Growth(%)-163.4297.15-8980.19416.36107.55
   EPS Growth(%)-163.4297.84-8980.19416.36107.55
Financial Stability Ratios
   Total Debt/Equity(x)-1.99-2.14-1.872.753.10
   Current Ratio(x)2.522.622.228.499.30
   Quick Ratio(x)2.472.561.968.359.28
   Interest Cover(x)-17.08-6.90-22.451.291.02
   Total Debt/Mcap(x)13.61

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.